Department of Psychiatry, Medical School of Dokuz Eylül University, Izmir, Turkey.
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1300-5. doi: 10.1016/j.pnpbp.2010.07.014. Epub 2010 Jul 24.
Schizophrenia patients had decreased levels of quality of life compared to normal population. The aim of this study was to investigate the impact of panic attacks on quality of life in patients with schizophrenia.
Eighty-eight patients with schizophrenia and 85 healthy subjects were included in the study. World Health Organization Quality of Life Instrument-Short Form (WHOQOL-Bref) was given to patients and healthy subjects to assess quality of life. Panic module of Structured Clinical Interview for DSM-IV (SCID) was administered to patients for diagnosis of panic attacks and panic disorder. Positive and Negative Syndrome Scale (PANSS) for symptom severity and Calgary Depression Scale (CDS) for depressive symptoms were administered to the patients.
Patients with schizophrenia demonstrated significantly lower scores compared to healthy controls in all domains of WHOQOL-Bref. Twenty-five patients (28.4%) with schizophrenia had panic attacks (PA) and 10 patients (11.4%) met criteria for panic disorder (PD). Schizophrenia patients with PA had significantly lower scores on psychological domain of WHOQOL-Bref compared to the patients without PA. Schizophrenic patients with panic attacks had higher CDS scores than patients without PA. In the multivariate regression analyses the variance in psychological domain of WHOQOL-Bref was explained by depression rather than panic attack.
In patients with schizophrenia comorbid panic attacks may have a negative impact on quality of life, which is associated with depression significantly. Panic attacks and depressive symptomatology must be examined comprehensively in order to improve quality of life in patients with schizophrenia.
与普通人群相比,精神分裂症患者的生活质量水平较低。本研究旨在探讨惊恐发作对精神分裂症患者生活质量的影响。
将 88 名精神分裂症患者和 85 名健康受试者纳入研究。使用世界卫生组织生活质量量表-简表(WHOQOL-Bref)评估患者和健康受试者的生活质量。采用 DSM-IV 结构临床访谈恐慌模块(SCID)对患者进行惊恐发作和惊恐障碍的诊断。阳性和阴性症状量表(PANSS)用于评估症状严重程度,卡尔加里抑郁量表(CDS)用于评估抑郁症状。
与健康对照组相比,精神分裂症患者在 WHOQOL-Bref 的所有领域得分均明显较低。25 名精神分裂症患者(28.4%)有惊恐发作(PA),10 名患者(11.4%)符合惊恐障碍(PD)的标准。有 PA 的精神分裂症患者在 WHOQOL-Bref 的心理领域得分明显低于无 PA 的患者。有惊恐发作的精神分裂症患者的 CDS 评分高于无 PA 的患者。在多变量回归分析中,WHOQOL-Bref 的心理领域的差异由抑郁而不是惊恐发作来解释。
在精神分裂症患者中,共病惊恐发作可能对生活质量产生负面影响,且与抑郁显著相关。为了改善精神分裂症患者的生活质量,必须全面检查惊恐发作和抑郁症状。